Press Releases: Archive

Select a different year:

SIEMENS COMPLETES HEPATITIS B TEST PANEL FOR THE HIGH-VOLUME LABORATORY AND INTRODUCES HEPATITIS B TESTING TO THE MID-VOLUME LABORATORY

July 2, 2008

DEERFIELD, Ill. July 2, 2008 - Siemens Healthcare Diagnostics received CE marking approval to sell the hepatitis B virus e-antigen (HBeAg) and antibody to the hepatitis B virus (anti-HBe) tests in the European marketplace. More

PREMIER HEALTHCARE ALLIANCE HONORS SIEMENS HEALTHCARE DIAGNOSTICS FOR EXCELLENCE IN SUPPLIER PERFORMANCE

June 23, 2008

MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. More

SIEMENS AND LABCORP ENTER AGREEMENT TO CO-DEVELOP NEW CLINICAL DIAGNOSTIC TESTS

May 8, 2008

DEERFIELD, IL. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. More

DONAL QUINN HEADS DIAGNOSTICS DIVISION OF SIEMENS’ HEALTHCARE SECTOR

May 6, 2008

Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More

SIEMENS RECEIVES FDA APPROVAL FOR THE VERSANT 440 MOLECULAR SYSTEM

February 18, 2008

DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More

SIEMENS HEALTHCARE DIAGNOSTICS LAUNCHES B12, FOLATE, AND FERRITIN TESTS ON ITS DIMENSION VISTA INTELLIGENT LAB SYSTEM

January 16, 2008

Deerfield, IL, January 16, 2008  Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More